IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v613y2023i7945d10.1038_s41586-022-05632-x.html
   My bibliography  Save this article

Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Author

Listed:
  • Christopher P. Vellano

    (The University of Texas MD Anderson Cancer Center)

  • Michael G. White

    (The University of Texas MD Anderson Cancer Center)

  • Miles C. Andrews

    (The University of Texas MD Anderson Cancer Center
    Monash University)

  • Manoj Chelvanambi

    (The University of Texas MD Anderson Cancer Center)

  • Russell G. Witt

    (The University of Texas MD Anderson Cancer Center)

  • Joseph R. Daniele

    (The University of Texas MD Anderson Cancer Center)

  • Mark Titus

    (The University of Texas MD Anderson Cancer Center)

  • Jennifer L. McQuade

    (The University of Texas MD Anderson Cancer Center)

  • Fabio Conforti

    (European Institute of Oncology, IRCCS)

  • Elizabeth M. Burton

    (The University of Texas MD Anderson Cancer Center)

  • Matthew J. Lastrapes

    (The University of Texas MD Anderson Cancer Center)

  • Gabriel Ologun

    (The University of Texas MD Anderson Cancer Center
    Guthrie Courtland Medical Center)

  • Alexandria P. Cogdill

    (The University of Texas MD Anderson Cancer Center
    Immunai)

  • Golnaz Morad

    (The University of Texas MD Anderson Cancer Center)

  • Peter Prieto

    (The University of Texas MD Anderson Cancer Center
    University of Rochester)

  • Alexander J. Lazar

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Yanshuo Chu

    (The University of Texas MD Anderson Cancer Center)

  • Guangchun Han

    (The University of Texas MD Anderson Cancer Center)

  • M. A. Wadud Khan

    (The University of Texas MD Anderson Cancer Center)

  • Beth Helmink

    (The University of Texas MD Anderson Cancer Center
    Washington University in St Louis)

  • Michael A. Davies

    (The University of Texas MD Anderson Cancer Center)

  • Rodabe N. Amaria

    (The University of Texas MD Anderson Cancer Center)

  • Jeffrey J. Kovacs

    (The University of Texas MD Anderson Cancer Center)

  • Scott E. Woodman

    (The University of Texas MD Anderson Cancer Center)

  • Sapna Patel

    (The University of Texas MD Anderson Cancer Center)

  • Patrick Hwu

    (The University of Texas MD Anderson Cancer Center
    Moffitt Cancer Center)

  • Michael Peoples

    (The University of Texas MD Anderson Cancer Center)

  • Jeffrey E. Lee

    (The University of Texas MD Anderson Cancer Center)

  • Zachary A. Cooper

    (The University of Texas MD Anderson Cancer Center
    AstraZeneca)

  • Haifeng Zhu

    (The University of Texas MD Anderson Cancer Center)

  • Guang Gao

    (The University of Texas MD Anderson Cancer Center)

  • Hiya Banerjee

    (Novartis Pharmaceuticals)

  • Mike Lau

    (Novartis Pharma)

  • Jeffrey E. Gershenwald

    (The University of Texas MD Anderson Cancer Center)

  • Anthony Lucci

    (The University of Texas MD Anderson Cancer Center)

  • Emily Z. Keung

    (The University of Texas MD Anderson Cancer Center)

  • Merrick I. Ross

    (The University of Texas MD Anderson Cancer Center)

  • Laura Pala

    (European Institute of Oncology, IRCCS)

  • Eleonora Pagan

    (University of Milan-Bicocca)

  • Rossana Lazcano Segura

    (The University of Texas MD Anderson Cancer Center)

  • Qian Liu

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Mikayla S. Borthwick

    (University of Texas MD Anderson Cancer Center)

  • Eric Lau

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Melinda S. Yates

    (University of Texas MD Anderson Cancer Center)

  • Shannon N. Westin

    (University of Texas MD Anderson Cancer Center)

  • Khalida Wani

    (The University of Texas MD Anderson Cancer Center)

  • Michael T. Tetzlaff

    (The University of Texas MD Anderson Cancer Center
    University of California)

  • Lauren E. Haydu

    (The University of Texas MD Anderson Cancer Center)

  • Mikhila Mahendra

    (The University of Texas MD Anderson Cancer Center)

  • XiaoYan Ma

    (The University of Texas MD Anderson Cancer Center)

  • Christopher Logothetis

    (The University of Texas MD Anderson Cancer Center)

  • Zachary Kulstad

    (The University of Texas MD Anderson Cancer Center)

  • Sarah Johnson

    (The University of Texas MD Anderson Cancer Center)

  • Courtney W. Hudgens

    (The University of Texas MD Anderson Cancer Center)

  • Ningping Feng

    (The University of Texas MD Anderson Cancer Center)

  • Lorenzo Federico

    (The University of Texas MD Anderson Cancer Center)

  • Georgina V. Long

    (The University of Sydney, and Royal North Shore and Mater Hospitals)

  • P. Andrew Futreal

    (The University of Texas MD Anderson Cancer Center)

  • Swathi Arur

    (The University of Texas MD Anderson Cancer Center)

  • Hussein A. Tawbi

    (The University of Texas MD Anderson Cancer Center)

  • Amy E. Moran

    (Oregon Health & Science University)

  • Linghua Wang

    (The University of Texas MD Anderson Cancer Center)

  • Timothy P. Heffernan

    (The University of Texas MD Anderson Cancer Center)

  • Joseph R. Marszalek

    (The University of Texas MD Anderson Cancer Center)

  • Jennifer A. Wargo

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

Abstract

No abstract is available for this item.

Suggested Citation

  • Christopher P. Vellano & Michael G. White & Miles C. Andrews & Manoj Chelvanambi & Russell G. Witt & Joseph R. Daniele & Mark Titus & Jennifer L. McQuade & Fabio Conforti & Elizabeth M. Burton & Matth, 2023. "Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy," Nature, Nature, vol. 613(7945), pages 3-3, January.
    • Handle: RePEc:nat:nature:v:613:y:2023:i:7945:d:10.1038_s41586-022-05632-x
    DOI: 10.1038/s41586-022-05632-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-022-05632-x
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-022-05632-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:613:y:2023:i:7945:d:10.1038_s41586-022-05632-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.